As healthcare becomes more tailored to the individual, genomic assessment of the individual and of localized tissues, such as tumors, CD Genomics helps life science practitioners better identify biomarkers that help to diagnose and treat disease.

CD Genomics is pivotal for preclinical testing of Cancer Susceptibility. From genomic testing of personal health to high volume sample processing, our rapid turnaround spread on discovery, development and implementation of biomarkers and customized treatment.More information, please visit the website: http://www.cd-genomics.com/Genetic-Testing-for-the-Cancer-Susceptibility.html